Provided by Tiger Trade Technology Pte. Ltd.

VanEck Healthcare TruSector ETF

29.33
-0.1113-0.38%
Volume:138
Turnover:4K
Market Cap:586.53K
PE:- -
High:29.33
Open:29.38
Low:29.33
Close:29.44
52wk High:30.68
52wk Low:24.78
Shares:20.00K
Float Shares:20.00K
Volume Ratio:0.21
T/O Rate:0.69%
Dividend:0.21
Dividend Rate:0.73%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

U.S. Stocks on the MOVE-SpaceX, Humana, Delta Air Lines

Reuters
·
20 mins ago

Piper Sandler recommends buying UnitedHealth on 2027 Star Ratings release

TIPRANKS
·
41 mins ago

Analysts Have Conflicting Sentiments on These Healthcare Companies: Envista Holdings (NVST), Bristol-Myers Squibb (BMY) and Eli Lilly & Co (LLY)

TIPRANKS
·
1 hour ago

Johnson & Johnson reports new two-year results from Phase 3 ICONIC-LEAD study

TIPRANKS
·
1 hour ago

J&J Says Phase 3 Iconic-LEAD Trial Shows Icotyde Sustains Plaque Psoriasis Clearance Through 2 Years

Reuters
·
1 hour ago

J&J - at Week 112, 72% Achieve Pasi 90, 70% Achieve Iga 0/1 with Icotyde

THOMSON REUTERS
·
1 hour ago

J&J - no New Safety Signals Identified for Icotyde Through Week 112

THOMSON REUTERS
·
1 hour ago

New Johnson & Johnson Icotyde® (Icotrokinra) Long-Term Data Demonstrate Robust 2-Year Results in the Treatment of Adults and Adolescents with Plaque Psoriasis

THOMSON REUTERS
·
1 hour ago

Eli Lilly announces new TOGETHER-PsO trial data

TIPRANKS
·
1 hour ago

Merck price target lowered to $163 from $166 at BofA

TIPRANKS
·
1 hour ago

Lilly Says Phase 3b Together-PsO Data Show Broader Biomarker Shifts with Taltz Plus Zepbound vs Taltz Alone

Reuters
·
1 hour ago

Eli Lilly price target lowered to $1,341 from $1,344 at BofA

TIPRANKS
·
1 hour ago

Eli Lilly - Taltz and Zepbound Together Show Greater Reductions in Inflammatory Immune Activity

THOMSON REUTERS
·
1 hour ago

Eli Lilly: Improvements were Maintained or Further Improved Through Week 52, with Safety Consistent with Known Profile of Each Respective Medicine

THOMSON REUTERS
·
1 hour ago

New Phase 3B Data on Lilly's Taltz (Ixekizumab) and Zepbound (Tirzepatide) Advance Understanding of the Interconnected Immune and Metabolic Biology in Adults with Psoriasis and Obesity

THOMSON REUTERS
·
1 hour ago

TD Cowen Cuts Price Target on UnitedHealth Group to $402 From $430

MT Newswires Live
·
1 hour ago

TD Cowen Cuts UnitedHealth PT Ahead of Q3 Results

Reuters
·
1 hour ago

Wells Fargo Adjusts Price Target on Merck & Co to $165 From $170

MT Newswires Live
·
2 hours ago

UnitedHealth : TD Cowen Cuts Target Price to $402 from $430

THOMSON REUTERS
·
2 hours ago

Top 3 Biotech Stocks To Watch In October 2026

Simply Wall St.
·
5 hours ago